- Vouliez-vous dire
- clinical laboratoria
Résultats de la recherche - 24 results
Efficacy and safety of antiparasitic therapy for neurocysticercosis in rural Tanzania: a prospective cohort study
medicines and health products- Quality of medical laboratories Efficacité et sécurité des vaccins, médicaments et produits de santé- Qualité des laboratoires médicaux Doeltreffendheid en veiligheid van ...
The performance of a point-of-care test for the diagnosis of Neurocysticercosis in a resource-poor community setting in Zambia- a diagnostic accuracy study.
from antiparasitic treatment. FUNDING: European and Developing Countries Clinical Trials Partnership (EDCTP) and the German Federal Ministry of Education and Research (BMBF). Health Topics: ...
QC as a basis for human application of phage therapy in Belgium
former Soviet Union. Unfortunately, the differences between Soviet medical practice and reporting of clinical data and the current regulatory standards upheld by Western countries make it impossible to ...
Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study.
a positive clinical outcome (general efficacy) and performed a regression analysis to identify functional relationships. The most common indications were lower respiratory tract, skin and soft tissue, and bone ...
Pyrogen testing of phage therapeutic products
contamination (e.g. cell wall debris) is a major safety concern as these pro-inflammatory agents can cause unwanted clinical reactions with potential detrimental outcome. The most common and potent pyrogens are ...
Evaluation of a point-of-care test for the diagnosis of Taenia solium neurocysticercosis in rural southern Tanzania: a diagnostic accuracy study.
This test could be considered to support policies on screening patients with suspected neurocysticercosis in clinical settings, which would allow appropriate referral for neuroimaging and ...
COVID-19 vaccine effectiveness against symptomatic infection and hospitalisation in Belgium, July 2021 to May 2022.
hospitalisation (VE h), given time since vaccination and prior infection.MethodsNationwide healthcare records from July 2021 to May 2022 on testing and vaccination were combined with a clinical hospital survey. We ...
Homologous versus heterologous prime-boost COVID-19 vaccination: impact on clinical severity of Omicron among hospitalized COVID-19 patients in Belgium
Publication Type: Scientific poster, presentation or proceeding Authors: Marjan Meurisse; Nina Van Goethem; Joris Van Loenhout; Toon Braeye; Lucy Catteau Source: European Society of Clinical ...
Importance of anti-SARS-CoV-2 assay antigenic composition as revealed by the results of the Belgian external quality assessment (EQA) scheme.
divergent results in the Belgian SARS-CoV-2 serology external quality assessment scheme. Sample IS /17575 was serum originating from a 30 years old male patient. 124 diagnostic laboratories analysed this ...
Poor antibody response to BioNTech/Pfizer COVID-19 vaccination in SARS-CoV-2 naïve residents of nursing homes.
Effectiveness and safety of vaccines, medicines and health products- Quality of medical laboratories Efficacité et sécurité des vaccins, médicaments et produits de santé- Qualité des laboratoires médicaux ...